Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a financiar el Programa Nacional de Detección Temprana de Cáncer de Seno y de Cuello Uterino (NBCCEDP) de los Centros para el Control y la Prevención de Enfermedades (CDC) con $265 millones de

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a financiar el Programa de Control del Cáncer Colorrectal (CRCCP) de los Centros para el Control y la Prevención de Enfermedades (CDC) con $51 millones de dólares en el año fiscal 2027.

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a aumentar el financiamiento para programas contra el cáncer de los Centros para el Control y la Prevención de Enfermedades (CDC) a un mínimo de $482.9 millones de dólares en el año fiscal 2027

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a financiar el Programa Nacional de Registros de Cáncer (NPCR) de los Centros para el Control y la Prevención de Enfermedades (CDC) con $63.4 millones de dólares en el año fiscal 2027.

Llamado a la acción: La Red de Acción contra el Cáncer de la Sociedad Americana contra el Cáncer (ACS CAN) insta al Congreso a respaldar un financiamiento sostenido de $310 millones USD

Access to lifesaving preventive services, including cancer screening, relies on federal preventive care recommendations and guidelines that determine which screenings, tests, and services health insurance plans must cover without cost sharing, including who is eligible, the age at which services

The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to increase funding for the Centers for Disease Control and Prevention’s (CDC) cancer programs to at least $482.9 million in Fiscal Year 2027.

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to fund the Centers for Disease Control and Prevention’s (CDC) National Program for Cancer Registries (NPCR) at $63.4 million in FY 2027. Established by Congress in 1992, the National Program for Cancer Registries suppo

Tobacco Control Resources:

In 1999, the U.S. Department of Justice (DOJ) filed a lawsuit against major tobacco manufacturers Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria to hold the industry accountable for more than 50 years of conspiring to defraud the public in violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. Big Tobacco, an industry which has for decades knowingly addicted and endangered the lives of millions of Americans for their own profit, must now post the truth about their deadly products, including at the point-of-sale (POS) for approximately 220,000 tobacco retailers.

The tobacco industry has a history of using litigation to avoid and delay laws and regulations enacted to safeguard the public. ACS CAN, with our tobacco control partners, has also relied on the courts to hold Big Tobacco accountable and to ensure the federal government is effectively implementing the Tobacco Control Act.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

  •  

Screening Resources:

Breast cancer is the most common cancer diagnosed in women in the U.S. Although there has been substantial progress in reducing breast cancer mortality in the US over the past several decades, there are persistent disparities, especially among Black women. Additionally, breast cancer incidence is increasing, with the steepest trends among young women under 50. In 2025, an estimated 316,950 women in the U.S. will be diagnosed with invasive breast cancer with an additional 59,080 cases of ductal carcinoma in situ (DCIS) in women, and 42,680 will die from the disease. 

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2025 to accelerate progress in reducing mortality from lung cancer. 

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

Our latest survey finds that cancer patients and survivors would be less likely to stay current with preventive care, including recommended cancer screenings, if the provision requiring these services be covered at no cost were repealed. This survey also explores the challenges of limited provider networks and the need for patient navigation.

  •  

Healthy Eating and Active Living Resources:

The American Cancer Society Cancer Action Network (ACS CAN) supports policies and funding that increase access to “Food is Medicine” (or food as medicine) initiatives and interventions intended to prevent, treat, or manage chronic diseases and often address food and nutrition insecurity.